Novel substituted tetrahydrotriazaacenaphthylene derivatives as potent CRF1 receptor antagonists
Corticotropin-releasing factor (CRF), a 41 amino acid peptide neurohormone synthesised by specific hypothalamic nuclei in the brain, is implicated in stress-related function. Antagonism of CRF1 receptors is an attractive therapeutic approach fo